GGrantIndex
Sort

15,842 grants matching pancreatic cancer

IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PANCREATIC ADENOCARCINOMA

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

OPTIMIZING RADIOIMMUNOTHERAPY FOR PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

ISLETS IN PANCREATIC CARCINOGENICITY

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

GENOTOXICITY OF ENVIRONMENTAL CHEMICALS IN THE PANCREAS

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

CORE--PANCREAS TUMOR SPORE TISSUE BANK

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

GENOTOXICITY OF ENVIRONMENTAL CHEMICALS IN THE PANCREAS

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

CORE--PANCREAS CANCER FAMILY REGISTRY

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PANCREATIC ADENOCARCINOMA

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2001 · CA

CORE--PANCREAS TUMOR SPORE TISSUE BANK

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

ISLETS IN PANCREATIC CARCINOGENICITY

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

CORE--PANCREAS CANCER FAMILY REGISTRY

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

CORE--PANCREAS CANCER FAMILY REGISTRY

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

OPTIMIZING RADIOIMMUNOTHERAPY FOR PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2002 · CA

AMYLIN AND ITS RELEASING FACTOR IN THE EARLY DIAGNOSIS OF PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

IMMUNOTHERAPY AND IMMUNODIAGNOSIS OF PANCREATIC ADENOCARCINOMA

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

ISLETS IN PANCREATIC CARCINOGENICITY

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

GENOTOXICITY OF ENVIRONMENTAL CHEMICALS IN THE PANCREAS

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

OPTIMIZING RADIOIMMUNOTHERAPY FOR PANCREATIC CANCER

$201,603
University Of Nebraska Medical Center · P50 · FY2000 · CA

Quantitative Photoacoustic Detection of Lymph-node Metastases

$201,540
Ernest Joseph Feleppa · Riverside Research Institute · R21 · FY2013 · EB

LEUKOCYTE-ENDOTHELIAL CELL ADHESION IN TUMOR IMMUNITY

$201,492
Roswell Park Cancer Institute Corp · R01 · FY2001 · CA

Discovery of combination therapy for KRAS mutant cancer

$201,459
Ji Luo · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Core C: In vivo Imaging, Dosimetry and Sensing of Photodynamic-Immune Responses and Synergies

$201,433
Brian William Pogue · Massachusetts General Hospital · P01 · FY2022 · CA

'Inefficient autophagy, mitochondrial dysfunction, and pancreatic tumorigenesis

$201,411
Anna S Gukovskaya · University Of California Los Angeles · P01 · FY2013 · CA